Author's posts
White House receives counteroffers from drug companies
All manufacturers participating in the first cycle of Medicare drug price negotiations have responded with counteroffers, according to the Department of Health and Human Services.
The news comes after HHS sent initial offers on February 1, as the agen…
Highmark unveils Alloyed Works in portfolio consolidation
Highmark Health has introduced Alloyed Works, which will unite its diversified business offerings in a single portfolio.
Primary care struggling, underinvested, report finds
The primary care workforce is struggling to meet the population’s demands, and doesn’t receive enough investment despite diminishing supply and growing demand, a new report has found.
White House strengthens religious liberty protections for social services beneficiaries
Nine federal agencies are now tasked with advancing the White House’s call for religious freedom and equity by finalizing a rule that restores religious liberty protections for beneficiaries of federally funded social services, such as job training and…
Walgreens to accept Medicare Advantage supplemental benefits online
Walgreens has said it’s the first community pharmacy to accept a broad array of Medicare Advantage supplemental benefits online, through its website and the Walgreens app, allowing eligible members to shop from a catalog of about 1,700 Shop Eligible Pr…
CarelonRx launching digital-first weight management program
Beginning this spring, CarelonRX, will launch a weight management program to provide support to members who are on weight loss journeys – including those who use GLP-1 medications. CarelonRx is the pharmacy services segment within Carelon, Elevance Hea…
Signify Health launching at-home arrhythmia testing
Signify Health, a subsidiary of CVS Health, will add a heart arrhythmia test to its Diagnostic and Preventive Services offering. The move is intended to broaden Signify’s range of in-home services designed to support earlier detection, diagnosis and ma…
FDA withdraws approval of cancer drug Pepaxto
The Food and Drug Administration has announced its final decision to withdraw approval of Pepaxto, which was approved for use in combination with dexamethasone to treat certain patients with multiple myeloma.
Nuvance Health set to join Northwell Health in integrated regional system
Northwell Health and Nuvance Health, both nonprofits, have entered into a strategic agreement to form a new integrated regional health system serving communities across two states. The proposed agreement will allow the organizations to come together fo…
Medicare Advantage patients see more care delays, struggle with affordability
In comparison to their traditional Medicare counterparts, Medicare Advantage patients are more likely to experience delays in care (22% vs. 13% for original Medicare). The delays in care for MA patients were largely due to the need to get prior approva…
